Literature DB >> 2514622

BRO beta-lactamases of Branhamella catarrhalis and Moraxella subgenus Moraxella, including evidence for chromosomal beta-lactamase transfer by conjugation in B. catarrhalis, M. nonliquefaciens, and M. lacunata.

R J Wallace1, V A Steingrube, D R Nash, D G Hollis, C Flanagan, B A Brown, A Labidi, R E Weaver.   

Abstract

Two closely related beta-lactamases, BRO-1 and BRO-2 (formerly called Ravasio and 1908), are found in Moraxella (Branhamella) catarrhalis. We screened strains of B. catarrhalis recovered in the United States since 1952 and identified the first beta-lactamase-positive isolate in August 1976. The prevalence of the enzymes among 394 clinical isolates from one Texas hospital has averaged 75% since testing began in 1983. Screening of isolates of Moraxella subgenus Moraxella revealed the BRO enzymes in two other human respiratory tract species, M. lacunata and M. nonliquefaciens, beginning in 1978. A different beta-lactamase with a pI of 6.4 predominated in other species of subgenus Moraxella. BRO-2 had a different isoelectric focusing pattern and was produced in lesser amounts than BRO-1, but the two enzymes were indistinguishable by substrate or inhibitor profile. BRO enzymes from B. catarrhalis, M. nonliquefaciens, and M. lacunata could be transferred by conjugation and, for B. catarrhalis, also by transformation to B. catarrhalis. Plasmid bands were demonstrated in 90% of M. nonliquefaciens and in one previously reported strain of B. catarrhalis, but no change in plasmid profiles was seen in beta-lactamase-positive recombinants, supporting previous studies that suggested the beta-lactamase genes are chromosomal.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2514622      PMCID: PMC172775          DOI: 10.1128/AAC.33.11.1845

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  51 in total

Review 1.  Characterization of beta-lactamases.

Authors:  K Bush
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

2.  Analysis of the relationship between ampicillin resistance and beta-lactamase production in Branhamella catarrhalis.

Authors:  E E Stobberingh; H J van Eck; A W Houben; C P van Boven
Journal:  Drugs       Date:  1986       Impact factor: 9.546

3.  A comparative study of eight distinct beta-lactamases synthesized by gram-negative bacteria.

Authors:  G W Jack; M H Richmond
Journal:  J Gen Microbiol       Date:  1970-04

4.  Novel beta-lactamase from Branhamella catarrhalis.

Authors:  A B Hoi-Dang; C Brive-Le Bouguenec; M Barthelemy; R Labia
Journal:  Ann Microbiol (Paris)       Date:  1978-10

5.  beta-Lactamase-producing Branhamella catarrhalis causing otitis media in children.

Authors:  A L Kovatch; E R Wald; R H Michaels
Journal:  J Pediatr       Date:  1983-02       Impact factor: 4.406

6.  Conjugal transfer of the gonococcal penicillinase plasmid.

Authors:  B I Eisenstein; T Sox; G Biswas; E Blackman; P F Sparling
Journal:  Science       Date:  1977-03-11       Impact factor: 47.728

7.  Cultural and chemical characterization of CDC groups EO-2, M-5, and M-6, Moraxella (Moraxella) species, Oligella urethralis, Acinetobacter species, and Psychrobacter immobilis.

Authors:  C W Moss; P L Wallace; D G Hollis; R E Weaver
Journal:  J Clin Microbiol       Date:  1988-03       Impact factor: 5.948

8.  Transfer of beta-lactamase genes of Neisseria gonorrhoeae by conjugation.

Authors:  L A Kirven; C Thornsberry
Journal:  Antimicrob Agents Chemother       Date:  1977-06       Impact factor: 5.191

9.  Emergence of beta-lactamase-producing strains of Branhamella catarrhalis as important agents of acute otitis media.

Authors:  P A Shurin; C D Marchant; C H Kim; G F Van Hare; C E Johnson; M A Tutihasi; L J Knapp
Journal:  Pediatr Infect Dis       Date:  1983 Jan-Feb

10.  The Multifactor Primary Prevention Trial in Göteborg, Sweden. Comparison with a previously untreated population sample.

Authors:  L Wilhelmsen; G Berglund; D Elmfeldt; O Samuelsson; K Svardsudd
Journal:  Drugs       Date:  1986       Impact factor: 9.546

View more
  36 in total

1.  Molecular characterization of the beta-lactamases from clinical isolates of Moraxella (Branhamella) catarrhalis obtained from 24 U.S. medical centers during 1994-1995 and 1997-1998.

Authors:  S S Richter; P L Winokur; A B Brueggemann; H K Huynh; P R Rhomberg; E M Wingert; G V Doern
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

Review 2.  In vitro antibacterial activity and pharmacodynamics of new quinolones.

Authors:  A Dalhoff; F-J Schmitz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-04-01       Impact factor: 3.267

3.  A cross-Canada surveillance of antimicrobial resistance in respiratory tract pathogens.

Authors:  R J Davidson; D E Low
Journal:  Can J Infect Dis       Date:  1999-03

4.  Genetic basis of tetracycline resistance in Moraxella (Branhamella) catarrhalis.

Authors:  M C Roberts; B A Brown; V A Steingrube; R J Wallace
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

5.  Multiplex PCR assay that identifies the major lipooligosaccharide serotype expressed by Moraxella catarrhalis clinical isolates.

Authors:  Katie J Edwards; Johanna M Schwingel; Anup K Datta; Anthony A Campagnari
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

Review 6.  Beta-lactamase nomenclature.

Authors:  George A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

7.  Interpretation of gram-stained sputa containing Moraxella (Branhamella) catarrhalis.

Authors:  S M Ainsworth; S B Nagy; L A Morgan; G R Miller; J L Perry
Journal:  J Clin Microbiol       Date:  1990-11       Impact factor: 5.948

Review 8.  Moraxella catarrhalis bacteremic pneumonia in adults: two cases and review of the literature.

Authors:  J Collazos; J de Miguel; R Ayarza
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-03       Impact factor: 3.267

Review 9.  Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.

Authors:  K McGregor; B J Chang; B J Mee; T V Riley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-04       Impact factor: 3.267

10.  Molecular characterization of the BRO beta-lactamase of Moraxella (Branhamella) catarrhalis.

Authors:  H J Bootsma; H van Dijk; J Verhoef; A Fleer; F R Mooi
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.